课题基金 / 基金详情

SURAMIN IN PATIENTS WITH AIDS AND AIDS RELATED ILLNESSES

SURAMIN IN PATIENTS WITH AIDS AND AIDS RELATED ILLNESSES
苏拉明治疗艾滋病和艾滋病相关疾病的患者
批准号：
3595099
负责人：
Donna Mildvan
金额：
$6.0万
依托单位：
BETH ISRAEL MEDICAL CTR (NEW YORK)
依托单位国家：
美国
项目类别：
财政年份：
1985
资助国家：
美国
项目状态：
未结题
起止时间：
1985-12-06 至
来源：
https://reporter.nih.gov/project-details/3595099
关键词：
AIDS Kaposi's sarcoma T lymphocyte antiAIDS agent antiviral agents dosage drug adverse effect high performance liquid chromatography human immunodeficiency virus 1 human subject human therapy evaluation neoplasm /cancer chemotherapy suramin

项目摘要

项目成果

Donna Mildvan的其他基金

相似基金

相关文献

中文摘要
翻译
本合同旨在评估苏拉明的活性和毒性
英文摘要
This contract is designed to evaluate the activity and toxicity of Suramin in patients with AIDS and AIDS-related illnesses, including non-Hodgkin's lymphoma. Patients will receive Suramin for a period of one year and a number of parameters will be monitored including virology, pharmacokinetics, immune status and clinical response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM IN AIDS
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM IN AIDS
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM IN AIDS
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM IN AIDS
海外基金